Annonce • Sep 11
PRL Global Ltd. (ASX:PRG) acquired Centrex Limited (ASX:CXM). PRL Global Ltd. (ASX:PRG) entering into a deed of company arrangement to acquire Centrex Limited (ASX:CXM) on July 22, 2025. Centrex Limited, currently under a deed of company arrangement, is undergoing a significant transition as all its shares are set to be transferred to PRL Global Limited. The Deed Administrators have filed an application in the Federal Court of Australia to approve this transfer, with a hearing scheduled for August 19, 2025. A Court Hearing was held on August 19, 2025 which resulted in the issuance of a Court Order giving leave for the transfer of all of the issued shares in Centrex Limited.
PRL Global Ltd. (ASX:PRG) completed the acquisition of Centrex Limited (ASX:CXM) on July 22, 2025. As previously advised to shareholders the transfer is for no consideration payable to shareholders of Centrex Limited. on September 10, 2025, the Deed of Company Arrangement for Centrex Limited and its subsidiary Agriflex Pty Ltd has been effectuated and as such these entities are no longer subject to any form of external administration. Centrex Limited is now owned and controlled by PRL. Annonce • Jul 24
PRL Global Ltd. (ASX:PRG) entering into a deed of company arrangement to acquire Centrex Limited (ASX:CXM). PRL Global Ltd. (ASX:PRG) entering into a deed of company arrangement to acquire Centrex Limited (ASX:CXM) on July 22, 2025. Centrex Limited, currently under a deed of company arrangement, is undergoing a significant transition as all its shares are set to be transferred to PRL Global Limited. The Deed Administrators have filed an application in the Federal Court of Australia to approve this transfer, with a hearing scheduled for August 19, 2025.
The transaction is subject to court approval. Annonce • Mar 06
Centrex Limited has withdrawn its Follow-on Equity Offering in the amount of AUD 10.411269 million. Centrex Limited has withdrawn its Follow-on Equity Offering in the amount of AUD 10.411269 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 863,415,160
Price\Range: AUD 0.012
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 4,190,560
Price\Range: AUD 0.012
Security Features: Attached Options
Transaction Features: Rights Offering Annonce • Jan 15
Centrex Limited has filed a Follow-on Equity Offering in the amount of AUD 10.411269 million. Centrex Limited has filed a Follow-on Equity Offering in the amount of AUD 10.411269 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 867,605,720
Price\Range: AUD 0.012
Security Features: Attached Options
Transaction Features: Rights Offering Reported Earnings • Oct 02
Full year 2024 earnings released: AU$0.026 loss per share (vs AU$0.016 loss in FY 2023) Full year 2024 results: AU$0.026 loss per share (further deteriorated from AU$0.016 loss in FY 2023). Revenue: AU$30.7m (up 18% from FY 2023). Net loss: AU$19.3m (loss widened 102% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 4% per year. New Risk • Oct 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (29% increase in shares outstanding). Market cap is less than US$100m (AU$34.7m market cap, or US$24.0m). Annonce • Sep 25
Centrex Limited, Annual General Meeting, Nov 26, 2024 Centrex Limited, Annual General Meeting, Nov 26, 2024. Board Change • Sep 11
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Non-Executive Chairman Peter Hunt was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Annonce • Sep 05
Centrex Limited Announces Resignation of Mr. Graham Chrisp as Non-Executive Director Centrex Limited announced the resignation of Non-Executive Director Mr. Graham Chrisp, effective as of close of business. The resignation follows Mr. Chrisp's leave of absence beginning on 27th June 2024 due to personal circumstances. Mr. Chrisp, a founding director of Centrex, served as the Company's CEO from 2003 to 2005. He then held the role of Non-Executive Director from 2011, before stepping into the position of Executive Chairman from 2019 to 2021. He was also a member of the Company's Remuneration and Nomination Committee and Audit and Risk Committee. Mr. Chrisp has been a long-term and supportive shareholder of Centrex and has overseen its transition from exploration to production. The Board wishes to thank Mr. Chrisp for his invaluable contributions to Centrex since the Company's inception. New Risk • Aug 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (39% increase in shares outstanding). Market cap is less than US$100m (AU$30.0m market cap, or US$20.2m). New Risk • Jan 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$55.9m market cap, or US$37.2m). New Risk • Nov 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$9.4m free cash flow). Earnings have declined by 35% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (9.8% increase in shares outstanding). Market cap is less than US$100m (AU$52.4m market cap, or US$33.6m). Annonce • Sep 26
Centrex Limited, Annual General Meeting, Nov 29, 2023 Centrex Limited, Annual General Meeting, Nov 29, 2023. Agenda: To discuss a re-election of Directors. New Risk • Sep 01
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$14m free cash flow). Earnings have declined by 46% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (8.4% increase in shares outstanding). Market cap is less than US$100m (AU$48.3m market cap, or US$31.3m). New Risk • Aug 17
New minor risk - Revenue size The company makes less than US$5m in revenue. Total revenue: AU$7.7m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$14m free cash flow). Earnings have declined by 46% per year over the past 5 years. Minor Risks Revenue is less than US$5m (AU$7.7m revenue, or US$5.0m). Market cap is less than US$100m (AU$67.6m market cap, or US$43.5m). Annonce • Feb 09
Centrex Limited Appoints Ms. Hiti Taluja as Chief Commercial Officer Centrex Limited announced the appointment of Ms. Hiti Taluja as Chief Commercial Officer. Ms. Taluja joins Centrex with a depth of experience in commodity trading, supply chain and strategic sourcing. She has over 20 years' experience gained through prominent organizations in the fertiliser industry including Trammo, Incitec Pivot Limited and Mosaic Fertilisers. Ms. Taluja brings an entrepreneurial approach to the organisation with expertise in leading and managing commercial operations for Australian and global fertiliser companies. Prior to joining Centrex, Ms Taluja's most recent roles included Regional Manager Australia for Trammo Inc. and Sourcing Manager for Incitec Pivot Limited (Australia). Ms Taluja holds an Executive MBA from Melbourne Business School, a Bachelor's Degree in Commerce from Delhi University and a Diploma in Software Engineering from the National Institute of Information and Technology, India and is a Fellow of the Institute of Chartered Shipbrokers. As Centrex's Chief Commercial Officer, Ms Taluja is responsible for the Company's commercial negotiations, including strategic sourcing, contract negotiations, phosphate sales, shipping and port coordination, compliance management and high-level stakeholder engagement. Executive Departure • Apr 06
Company Secretary has left the company On the 31st of March, John Santich's tenure as Company Secretary ended after less than a year in the role. We don't have any record of a personal shareholding under John's name. A total of 2 executives have left over the last 12 months.